Knockdown of PTGS2 by CRISPR/CAS9 System Designates a New Potential Gene Target for Melanoma Treatment

CRISPR/Cas9 has become a powerful method to engineer genomes and to activate or to repress genes expression. As such, in cancer research CRISPR/Cas9 technology represents an efficient tool to dissect mechanisms of tumorigenesis and to discover novel targets for drug development. Here, we employed th...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Giuseppe Ercolano (Egilea), Paola De Cicco (Egilea), Valentina Rubino (Egilea), Giuseppe Terrazzano (Egilea), Giuseppina Ruggiero (Egilea), Roberta Carriero (Egilea), Paolo Kunderfranco (Egilea), Angela Ianaro (Egilea)
Formatua: Liburua
Argitaratua: Frontiers Media S.A., 2019-12-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri